B. Oosterhuis

Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs

Graham Lappin, W. Kuhnz, R. Jochemsen et al. · Clinical Pharmacology & Therapeutics · 2006 · 241 citations

Metabolism and Excretion of the Once-Daily Human Glucagon-Like Peptide-1 Analog Liraglutide in Healthy Male Subjects and Its In Vitro Degradation by Dipeptidyl Peptidase IV and Neutral Endopeptidase

Monika Malm-Erjefält, Inga Bjørnsdottir, Jan Vanggaard et al. · Drug Metabolism and Disposition · 2010 · 195 citations

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences

Wim J. Tamminga, J. Wemer, B. Oosterhuis et al. · European Journal of Clinical Pharmacology · 1999 · 143 citations

Contraception, Hormonal Contraceptive, Oral Contraceptive +10

Pharmacokinetics of fexofenadine: Evaluation of a microdose and assessment of absolute oral bioavailability

Graham Lappin, Yoko Shishikura, Roeline Jochemsen et al. · European Journal of Pharmaceutical Sciences · 2010 · 113 citations

Therapeutic Drug Monitoring, Pharmacokinetic Modeling, Medicine +4

The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers

Wim J. Tamminga, J. Wemer, B. Oosterhuis et al. · European Journal of Clinical Pharmacology · 2001 · 99 citations

Genetic Epidemiology, Human Polymorphism, Cyp2c19 Genotypes +5